RETRACTED ARTICLE: Lactobacillus casei BL23 regulates Treg and Th17 T-cell populations and reduces DMH-associated colorectal cancer
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Background Chronic intestinal inflammation alters host physiology and could lead to colorectal cancer (CRC). We have previously reported beneficial effects of the probiotic strain of Lactobacillus casei BL23 in different murine models of intestinal inflammation. In addition, there is an emerging interest on the potential beneficial effects of probiotics to treat CRC. We thus explored whether L. casei BL23 displays protective effects on CRC.Methods Mice were subcutaneously injected with 1,2-dimethylhydrazine (DMH) weekly during 10 weeks and orally administered with L. casei BL23 in the drinking water until the 10th week. Multiple plaque lesions in the large intestine were observed macroscopically and counted and intestinal tissues were also histologically analyzed. Finally, T-cell populations and cytokine production were evaluated after co-incubation of L. casei BL23 with spleen cells from non-treated mice to determine the immuno-modulatory effects of this bacterium.Results Our results show that oral treatment with this probiotic bacterium modulates host immune responses and significantly protect mice against DMH-induced CRC. This protection may be associated with the modulation of regulatory T-cells towards a Th17-biased immune response accompanied by the expression of regulatory cytokines (IL-6, IL-17, IL-10 and TGF-β), as demonstrated in L. casei BL23-treated splenocytes, but also with the colonic expression of IL-22 observed in vivo on L. casei BL23-treated mice; suggesting the induction of a fine-tune Th17-biased response.Conclusions Altogether our results reveal the high potential of L. casei BL23 to treat CRC and opens new frontiers for the study of immunomodulatory functions of probiotics.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“It has been also reported in several studies that Lactobacilli may stimulate host’s immune cells such as NK cells or dendritic cells (DC) or TH1 response, which, in turn, leads to the elimination of cancerous or precancerous cells, although the exact bacterial bioproduct mediating such stimulatory effect still needs to be identified [45,46,47,48].”
From Gut Microbiota and Cancer: From Pathogenesis to Therapy (2019) · cites this paper as [45]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bradford, M. M. (1976) · Analytical Biochemistry · doi:10.1016/0003-2697(76)90527-3 · Cited by 255,302 · cited 1×
“method of Bradford [32].”
Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method
Livak, K. J., & Schmittgen, T. D. (2001) · Methods · doi:10.1006/meth.2001.1262 · Cited by 180,860
Siegel, R., Naishadham, D., & Jemal, A. (2013) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21166 · Cited by 11,825
Mutation of the mouse klotho gene leads to a syndrome resembling ageing
Kuro-o, M., Matsumura, Y., Aizawa, H., Kawaguchi, H., Suga, T., Utsugi, T., Ohyama, Y., Kurabayashi, M., Kaname, T., Kume, E., et al. (1997) · Nature · doi:10.1038/36285 · Cited by 3,837
The Intestinal Microbiota Modulates the Anticancer Immune Effects of Cyclophosphamide
Viaud, S., Saccheri, F., Mignot, G., Yamazaki, T., Daillère, R., Hannani, D., Enot, D. P., Pfirschke, C., Engblom, C., Pittet, M. J., et al. (2013) · Science · doi:10.1126/science.1240537 · Cited by 2,050 · cited 1×
“Currently, some studies have demonstrated that both probiotic bacteria and gut microbiota [2] could be an alternative approach to prevent and treat a number of human diseases including cancer and CRC [3, 4].”
BackgroundGasson, M. J. (1983) · Journal of Bacteriology · doi:10.1128/jb.154.1.1-9.1983 · Cited by 1,322 · cited 7×
“Data are represented as individual tumors volumes from mice at the end of week 10 (median of the size is shown by bars), Student’s t test, *p\ 0.001 (A) (B) Microscopic damage score Mo nth 3 Mo nth 4 Mo nth 5 Mo nth 6 0 2 4 6 8 10 12 DMH L. lactis MG1363 L. casei BL23 M ic ro sc op ic s co re ** MPL Mo nth 3 Mo nth 4…”
MethodInfluentialTosolini, M., Kirilovsky, A., Mlecnik, B., Fredriksen, T., Mauger, S., Bindea, G., Berger, A., Bruneval, P., Fridman, W.-H., Pagès, F., et al. (2011) · Cancer Research · doi:10.1158/0008-5472.can-10-2907 · Cited by 1,146 · cited 1×
“and an increase in Treg populations are most related to a beneficial effect in cancer (including CRC) [39–42].”
BackgroundLin, K. Y., Guarnieri, F., Staveley-O’Carroll, K. F., Levitsky, H. I., August, J. T., Pardoll, D. M., & Wu, T. ‐. (1996) · PubMed · Cited by 1,003
The microbiota regulates type 2 immunity through RORγt + T cells
Ohnmacht, C., Park, J.-H., Cording, S., Wing, J. B., Atarashi, K., Obata, Y., Gaboriau-Routhiau, V., Marques, R., Dulauroy, S., Fedoseeva, M., et al. (2015) · Science · doi:10.1126/science.aac4263 · Cited by 863
Lactobacillus species prevents colitis in interleukin 10 gene–deficient mice
Madsen, K. L., Doyle, J. S., Jewell, L. D., Tavernini, M. M., & Fedorak, R. N. (1999) · Gastroenterology · doi:10.1016/s0016-5085(99)70013-2 · Cited by 761 · cited 3×
“For example, it has been reported that administration of Lactobacillus reuteri prevented colitis in IL-10 KO mice by increasing the number of LAB in the GIT [7].”
Background
Cited by
Items 101–157 of 157
Alamdary, S. Z., Halimi, S., Rezaei, A., & Afifirad, R. (2023) · Canadian Journal of Infectious Diseases and Medical Microbiology · doi:10.1155/2023/3571184 · Cited by 11
Systematic review on the role of the gut microbiota in tumors and their treatment
Shi, Y., Li, X., & Zhang, J. (2024) · Frontiers in Endocrinology · doi:10.3389/fendo.2024.1355387 · Cited by 14
Chang, M. R., Rusanov, D. A., Arakelyan, J., Alshehri, M. M., Asaturova, A. V., Kireeva, G. S., Babak, M. V., & Ang, W. H. (2022) · Coordination Chemistry Reviews · doi:10.1016/j.ccr.2022.214923 · Cited by 12
Hadad, S. E., Alsolami, M., Aldahlawi, A., Alrahimi, J., Basingab, F. S., Hassoubah, S. A., & Alothaid, H. (2021) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2021.04.090 · Cited by 10
“CRC is more common among males than females and three to four times more prevalent in both sexes in developed than in developing countries (Shaukat et al., 2013; Smyth et al., 2018).”
BackgroundInfluentialKuo, S. (2017) · Current Developments in Nutrition · doi:10.3945/cdn.117.001180 · Cited by 10
“Probiotic Bifidobacterium bifidum PRL2010 (109), Lactobacillus reuteri (110), or Lactobacillus casei BL23 (111) reduced chemical-induced colitis or lesions in chow-fed mice.”
BackgroundCui, Y., Xu, Z., Yue, Y., Kong, W., Kong, J., & Guo, T. (2024) · Microbial Cell Factories · doi:10.1186/s12934-024-02586-9 · Cited by 9
Marandi, A., Ashrafi, F., & Bakhtiari, N. (2023) · Iranian Journal of Science · doi:10.1007/s40995-023-01460-4 · Cited by 9
“Earlier research has linked this antineoplastic impact to immune response regulation, specifically the modulation of regulatory T-cells toward a Th17-biased immune response involved in the production of regulatory cytokines (IL-6, IL-17, IL-10, and TGF-b) (Lenoir et al. 2016).”
BackgroundUnderstanding the microbiome: a primer on the role of the microbiome in colorectal neoplasia
Watson, K. M., Gaulke, C. A., & Tsikitis, V. L. (2020) · Annals of Gastroenterology · doi:10.20524/aog.2020.0467 · Cited by 10
“Additionally, Lactobacillus and Bifidobacterium have been shown to aid in restoring a normal balance of intestinal flora [147,148].”
BackgroundGhanavati, R., Mohammadi, F., Javadi, A., Shahosseini, Z., Talebi, M., & Rohani, M. (2020) · PharmaNutrition · doi:10.1016/j.phanu.2020.100207 · Cited by 9
Nutrition, Immunity, and Cancer
Ghaedi, E., Rezaei, N., & Mahmoudi, M. (2019) · Springer eBooks · doi:10.1007/978-3-030-16073-9_12 · Cited by 9
Decreased mucosal adhesion of Lactobacillus species in patients with inflammatory bowel disease.
Najafi, S., Sotoodehnejadnematalahi, F., Amiri, M. M., Pourshafie, M. R., & Rohani, M. (2022) · PubMed Central · doi:10.22088/cjim.13.4.71 · Cited by 10
“Mice studies revealed that adhesion of commensal bacteria to the GI mucosa in IBD patients provokes interleukin 17 (IL-17) secretion from T helper 17 (Th17) cells to levels that lead to severe inflammatory response (9-12).”
BackgroundRecent advances in the development and application of colorectal cancer mouse models
Wang, T., Chen, Z., Zhang, Y., Liu, M., Sui, H. X., & Tang, Q. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1553637 · Cited by 8
Microbiota intestinal y cáncer
Veintimilla, D. R., & Frías-Toral, E. (2021) · Revista de Nutrición Clínica y Metabolismo · doi:10.35454/rncm.v4n1.175 · Cited by 10
Lata, P., Sharma, K. B., Rangra, S., Kumari, R., & Savitri (2023) · Journal of Microbiology Biotechnology and Food Sciences · doi:10.55251/jmbfs.5817 · Cited by 8
do Nascimento, F. S., Suzuki, M. O., Taba, J. V., de Mattos, V. C., Pipek, L. Z., D’Albuquerque, E. M. C., Iuamoto, L. R., Meyer, A., Andraus, W., Pinho, J. R. R., et al. (2020) · PLoS ONE · doi:10.1371/journal.pone.0242553 · Cited by 8
“Thus, the microbe proved to be a protector and a new therapeutic alternative to carcinoma [11, 13].”
BackgroundMicrobial Interactions and Interventions in Colorectal Cancer
Raay, T. J. V., & Allen‐Vercoe, E. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch4 · Cited by 9
Mahooti, M., Safaei, F., Firuzpour, F., Abdolalipour, E., Zare, D., Sanami, S., Safavi, M., & Mirdamadi, S. (2025) · Inflammopharmacology · doi:10.1007/s10787-025-01855-2 · Cited by 8
“In different studies, the authors concluded that the potential of the studied probiotics to reduce pro-inflammatory cytokines is associated with their anti-cancer effects, although more research is needed (Jacouton et al. 2019; Lenoir et al. 2016).”
Utz, V. E. M., Perdigón, G., & de LeBlanc, A. D. M. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-809868-4.00026-1 · Cited by 9
Shonyela, S. M., Wang, G., Yang, W., Yang, G., & Wang, C. (2017) · World Journal of Vaccines · doi:10.4236/wjv.2017.74004 · Cited by 6
Lactic acid bacteria in gut microbiota, probiotics and disease prevention
Aburjaile, F. F., de Jesus, L. C. L., da Silva, T. F., Drumond, M. M., Carvalho, R. D. D. O., Azevedo, V., & Mancha-Agresti, P. D. C. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-89875-1.00001-8 · Cited by 7
Tavakoli, S., Gholami, M. H., Ghorban, K., Nojoumi, F., Faghihloo, E., Dadmanesh, M., & Rouzbahani, N. H. (2021) · Gene Reports · doi:10.1016/j.genrep.2021.101025 · Cited by 6
Bacterial Peptides and Bacteriocins as Novel Treatment for Prostate Cancer
Ye, K., Ke, Z., Zhang, X., Liang, K., Zhang, Q., & Huang, J. (2023) · International Journal of Peptide Research and Therapeutics · doi:10.1007/s10989-023-10544-z · Cited by 6
Oral supplementation with lactobacilli to prevent colorectal cancer in preclinical models
Settanni, C. R., Quaranta, G., Bibbò, S., Gasbarrini, A., Cammarota, G., & Ianiro, G. (2020) · Minerva Gastroenterologica e Dietologica · doi:10.23736/s1121-421x.19.02631-x · Cited by 5
Gradaschi, V., Payaslián, F., Dieterle, M. E., Rondón, L., Urdániz, E., Paola, M. D., Cárcamo, J. P., Zon, F., Allievi, M. C., Sosa, E. J., et al. (2020) · PHAGE · doi:10.1089/phage.2020.0029 · Cited by 5
The Impact of the Intestinal Microbiota in Therapeutic Responses Against Cancer
Bonvalet, M., Daillère, R., Roberti, M. P., Rauber, C., & Zitvogel, L. (2017) · Springer eBooks · doi:10.1007/978-3-319-62431-0_27 · Cited by 5
High-fat Diet Induced Dysbiosis & Amelioration by Astaxanthin
Haasbroek, K., Takabe, W., Yagi, M., & Yonei, Y. (2019) · Rad Hrvatske akademije znanosti i umjetnosti Medicinske znanosti · doi:10.21857/9xn31crexy · Cited by 8
Gut Microbiota and Cancer Correlates
Malaviya, A., Paari, K. A., Malviya, S., Kondapalli, V. K., Ghosh, A., & Samuel, R. A. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_1 · Cited by 5
Probiotics in Lung Cancer: An Emerging Field of Multifarious Potential and Opportunities
Kurakula, M., & Rao, G. K. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_7 · Cited by 4
Lenoir, M., del Carmen, S., Cortes‐Perez, N. G., Lozano‐Ojalvo, D., Muñoz-Provencio, D., Chain, F., Langella, P., de LeBlanc, A. D. M., LeBlanc, J. G., & Bermúdez‐Humarán, L. G. (2020) · Journal of Gastroenterology · doi:10.1007/s00535-020-01722-7 · Cited by 4
Self-citationSoleymani, S., Ebrahimi, F., Rezaeizadeh, H., & Rahimi, R. (2021) · Food bioactive ingredients · doi:10.1007/978-3-030-74035-1_18 · Cited by 6
Microbiome Diagnostics and Interventions in Health and Disease
Dasgupta, N., Srivastava, A., Rao, A., Murugkar, V., Shroff, R., & Das, G. (2021) · Springer eBooks · doi:10.1007/978-981-16-3156-6_10 · Cited by 5
Human microbiota: role in cancer progression and therapy
Rais, A., Chand, P., Malik, M., & Prasad, T. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-96128-8.00006-7 · Cited by 3
Insights into the Suppression of Multidrug-Resistant Helicobacter pylori by Probiotics Supernatant
Lv, C., Jia, F., Bai, X., Wang, D., Chen, Y., Ding, J., & Fang, L. (2019) · Jundishapur Journal of Microbiology · doi:10.5812/jjm.91797 · Cited by 3
Probiotics as Potential Therapeutics for Colorectal Cancer
Chung, M. J. (2020) · American Journal of Biomedical Science & Research · doi:10.34297/ajbsr.2020.09.001362 · Cited by 3
“rhamnosus suppresses tumor development, progression, and volume by inactivating NF-kB; this in turn dampens proinflammatory responses and angiogenesis, both of which play central roles in tumor development and progression [39].”
BackgroundPotential of Probiotics in the Management of Lung Cancer
Divyashri, G., Murthy, T. P. K., & Murahari, M. (2020) · Springer eBooks · doi:10.1007/978-981-15-8214-1_10 · Cited by 3
Lactic Acid Bacteria and Gut Health
Li, H., & Fang, Z. (2019) · Springer eBooks · doi:10.1007/978-981-13-7832-4_8 · Cited by 2
Enterococcus faecium 137v como fator de proteção em modelo animal para câncer colorretal
Calaça, P. R. D. A., Santos, D. D. S., Ferreira, J. D. S., Aragão, A. B. L., de Melo, I. M. F., da Silva, E. C. S., Porto, A. L. F., & Cavalcanti, M. T. H. (2021) · Research Society and Development · doi:10.33448/rsd-v10i6.15354 · Cited by 3
Use of Traditional and Genetically Modified Probiotics in Human Health: What Does the Future Hold?
Bermúdez‐Humarán, L. G., & Langella, P. (2018) · ASM Press eBooks · doi:10.1128/9781555819705.ch15 · Cited by 2
Self-citationLi, L., Zhao, C., Kong, F., Li, Y., Wang, C., Chen, S., Tan, H., Liu, Y., & Wang, D. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.898906 · Cited by 3
“2 CTP Regulated the Intestinal Microbiota in Apc Mice Intestinal microbiota can influence the occurrence and development of CRC (Lenoir et al., 2016; Yamaoka et al., 2018).”
BackgroundEvaluation of Enterococcus faecium EF137v on colorectal carcinogenesis
Calaça, P. R. D. A., Santos, D. D. S., Ferreira, J. D. S., Aragão, A. B. L., de Melo, I. M. F., Teixeira, Á. A. C., Teixeira, V. W., Porto, A. L. F., & Cavalcanti, M. T. H. (2025) · Anais da Academia Brasileira de Ciências · doi:10.1590/0001-3765202520240896 · Cited by 2
Longoria-García, S., Belmares, R. E., Flores-Verástegui, M. I. M., Contreras‐Esquivel, J. C., Montañez, J., & Cruz, M. (2016) · InTech eBooks · doi:10.5772/63643 · Cited by 2
“[40] L.”
Preclinical Models in Colorectal Cancer Drug Discovery
Yang, Y., Meng, W., & Wang, Z. (2023) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-3824-5_56 · Cited by 1
Advances in Cancer Therapeutics: Potential Probiotics on Cancer Therapy
Ghosh, A. R., & George, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-2196-6_46-1 · Cited by 2
Importance of the Microbiome and the Metabolome in Cancer
dos Santos, L. M., de Andrade, A. C. M. M., & Lopes, M. E. (2019) · Elsevier eBooks · doi:10.1016/b978-0-12-815249-2.00038-5
Lucas, C. (2018) · theses.fr (ABES) · doi:10.70675/8c2a9041zc9bcz4cabzbe6cz5b5453a81fa4 · Cited by 1
“La souche Lactobacillus casei BL23 a aussi été montrée comme pouvant diminuer le nombre de tumeurs coliques dans un modèle murin de CCR induit chimiquement par le 1,2-dimethylhydazine (Lenoir et al., 2016).”
BackgroundProbiotic Microorganism: A Promising and Innovative Tool for Cancer Prevention and Therapy
Debnath, N., Yadav, A. K., & Tyagi, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-822909-5.00012-5
Preclinical Models in Colorectal Cancer Drug Discovery
Yang, Y., Meng, W., & Wang, Z. (2022) · Handbook of Animal Models and its Uses in Cancer Research · doi:10.1007/978-981-19-1282-5_56-1
Novel Nutritional Therapies for Cancer Treatment and Their Possible Immunological Pathways
Ghaedi, E., & Rezaei, N. (2023) · Springer eBooks · doi:10.1007/978-3-030-80962-1_104-1
Advances in Cancer Therapeutics: Potential Probiotics on Cancer Therapy
Ghosh, A. R., & George, J. (2024) · Springer eBooks · doi:10.1007/978-981-99-6263-1_46
Zhao, H., Li, H., Zhao, Y., Wu, T., Deng, Y.-L., Hou, Y., Zhang, W., Man, C., Zhang, Y., Zhao, Q., et al. (2024) · Food Science and Human Wellness · doi:10.26599/fshw.2024.9250334
“The consumption of L. casei BL23 in untreated mice has been observed to increase the expression of cytokines IL-6 and IL-17 and to shift Treg to Th17, thereby conferring protection against colorectal cancer [125] .”
Novel Nutritional Therapies for Cancer Treatment and Their Possible Immunological Pathways
Ghaedi, E., & Rezaei, N. (2025) · Springer eBooks · doi:10.1007/978-3-032-00771-1_104
张, 天. (2025) · Advances in Clinical Medicine · doi:10.12677/acm.2025.15123583
Zhao, Z., Yang, Q., Zhou, T., Liu, C., Sun, M., Cui, X., & Zhang, X. (2024) · Figshare · doi:10.6084/m9.figshare.26617105
Role of the gut microbiome in the development of colorectal cancer
Shanbhag, A. P. (2026) · Elsevier eBooks · doi:10.1016/b978-0-443-40483-2.00040-6
Qu, Y., Wang, X., Zhang, Q., & Xing, Z. (2026) · Journal of the Iranian Chemical Society · doi:10.1007/s13738-026-03699-1
Metadata
- Authors
- Lenoir, M., del Carmen, S., Cortes-Perez, N. G., Lozano-Ojalvo, D., Muñoz-Provencio, D., Chain, F., Langella, P., de Moreno de LeBlanc, A., LeBlanc, J. G., & Bermúdez-Humarán, L. G.
- Affiliations
- AgroParisTech (FR)
- Consejo Nacional de Investigaciones Científicas y Técnicas (AR)
- Corresponding author
- LeBlanc, Jean Guy
- Venue
- Journal of Gastroenterology
- Published
- 2016-01-09
- Volume
- 51
- Issue
- 9
- Pages
- 862-873
- ISSN
- 0944-1174 (ISSN-L)
- 1435-5922
- OpenAlex
- W2227234059
- Cited by
- 155
- References
- 46
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 9 · 2023: 12 · 2022: 15 · 2021: 17 · 2020: 35 · 2019: 23 · 2018: 17 · 2017: 17 · 2016: 4
- FWCI
- 25.61
- Type
- journal article
- Language
- en
- Status
- Retracted
- Update notices
- retraction (2020-09-08)
- Open access
- bronze
- doi.org
- Licence
- www.springer.com/tdm (tdm)
- www.springer.com/tdm (vor)
- Locations
- Journal of Gastroenterology (publishedVersion)
- PubMed (publishedVersion)
- HAL (submittedVersion)
- DIGITAL.CSIC (Spanish National Research Council (CSIC)) (submittedVersion)
- CONICET Digital (CONICET) (submittedVersion, cc-by-nc-sa)
- Funders
- Ministerio de Educación, Cultura y Deporte
- Topics
- Life Sciences › Agricultural and Biological Sciences › Food Science › Probiotics and Fermented Foods
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biotechnology › Bacterial Cancer Therapy
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Keywords
- probiotics, colorectal cancer, 1,2-dimethylhydrazine, regulatory T cells, Th17 cells, immunomodulation, intestinal inflammation, IL-22, IL-17, IL-10, TGF-beta, interleukin-6, retracted article
- MeSH terms
- Animals, Female, Lacticaseibacillus casei, Mice, Inbred BALB C, Mice, Inbred C57BL, Colorectal Neoplasms, Biomarkers, Cytokines, 1,2-Dimethylhydrazine, Probiotics, T-Lymphocytes, Regulatory, Mice, Th17 Cells
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.